Target Healthcare REIT

Target Healthcare REIT delivered a total accounting return of 6.8% in the first half of 2025 and recorded its highest half-year profit since 2013. EPRA result per share rose 8.5% to 0.034 GBP, and the dividend was increased by 2.5% to 0.0302 GBP. The loan-to-value ratio fell to 15%; portfolio adjustments included the sale of 10 care homes and the acquisition of three assets. Management plans further acquisitions with expected net initial yields above 6% and aims for a long-term LTV of around 25%. » More on de.investing.com

Target Healthcare REIT reports EPRA net asset value rising to 117.7 pence (+2.5%) after the sale of nine care homes for £85.9 million. Adjusted EPRA earnings per share rose to 1.71 pence, supporting a dividend of 1.508 pence (+2.5%). Portfolio value climbed to £948.3 million, EPRA "topped-up" NIY is 6.24%, contracted rents increased by 1.8%, and net LTV fell to 21.4% with £138 million of capital available for reinvestment. Refinancing extended average debt maturity to 5.9 years, with £200 million fixed at 3.89% until 2030. » More on de.investing.com